نتائج البحث - "Miceli, Rosa"

1

دورية أكاديمية

Italian Guidelines For The Management Of Non-Functioning Benign And Locally Symptomatic Thyroid Nodules

المساهمون: Papini, Enrico, Crescenzi, Anna, D'Amore, Annamaria, Deandrea, Maurilio, De Benedictis, Anna, Frasoldati, Andrea, Garberoglio, Roberto, Guglielmi, Rinaldo, Pio Lombardi, Celestino, Mauri, Giovanni, Elisa Miceli, Rosa, Puglisi, Soraya, Rago, Teresa, Salvatore, Domenico, Triggiani, Vincenzo, Van Doorne, Dominique, Mitrova, Zuzana, Saulle, Rosella, Vecchi, Simona, Basile, Michele, Scoppola, Alessandro, Paoletta, Agostino, Persichetti, Agnese, Samperi, Irene, Cozzi, Renato, Grimaldi, Franco, Boniardi, Marco, Camaioni, Angelo, Elisei, Rossella, Guastamacchia, Edoardo, Nati, Giulio, Novo, Tommaso, Salvatori, Massimo, Spiezia, Stefano, Vallone, Gianfranco, Zini, Michele, Attanasio, Roberto

مصطلحات موضوعية: Ablation, Ethanol injection, HIFU, Hemi-thyroidectomy, Laser, Microwave, Radiofrequency, Surgery, Thermo-ablation, Thyroid nodule, Thyroidectomy, Ultrasound

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36722479; info:eu-repo/semantics/altIdentifier/wos/WOS:001004356700015; volume:23; issue:6; firstpage:876; lastpage:885; numberofpages:10; journal:ENDOCRINE, METABOLIC & IMMUNE DISORDERS DRUG TARGETS; https://hdl.handle.net/11573/1700050Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85153397448

الإتاحة: https://doi.org/10.2174/1871530323666230201104112Test
https://hdl.handle.net/11573/1700050Test

View record in BASE

2

دورية أكاديمية

Safety and Tolerability Results of Atogepant for the Preventive Treatment of Episodic Migraine From a 40-Week, Open-Label Multicenter Extension of the Phase 3 ADVANCE Trial

المؤلفون: Klein, Brad C, Miceli, Rosa, Severt, Lawrence, McAllister, Peter, Mechtler, Laszlo, McVige, Jennifer, Diamond, Merle, Marmura, Michael J, Guo, Hua, Finnegan, Michelle, Trugman, Joel M

المصدر: Department of Neurology Faculty Papers

مصطلحات موضوعية: Humans, Treatment Outcome, Double-Blind Method, Migraine Disorders, Nausea, Medicine and Health Sciences, Neurology

وصف الملف: application/pdf

العلاقة: https://jdc.jefferson.edu/neurologyfp/311Test; https://jdc.jefferson.edu/cgi/viewcontent.cgi?article=1318&context=neurologyfpTest

الإتاحة: https://jdc.jefferson.edu/neurologyfp/311Test
https://jdc.jefferson.edu/cgi/viewcontent.cgi?article=1318&context=neurologyfpTest

View record in BASE

3

دورية أكاديمية

Once-daily oral atogepant for the long-term preventive treatment of migraine:Findings from a multicenter, randomized, open-label, phase 3 trial

المؤلفون: Ashina, Messoud, Tepper, Stewart J., Reuter, Uwe, Blumenfeld, Andrew M., Hutchinson, Susan, Xia, Jing, Miceli, Rosa, Severt, Lawrence, Finnegan, Michelle, Trugman, Joel M.

المصدر: Ashina , M , Tepper , S J , Reuter , U , Blumenfeld , A M , Hutchinson , S , Xia , J , Miceli , R , Severt , L , Finnegan , M & Trugman , J M 2023 , ' Once-daily oral atogepant for the long-term preventive treatment of migraine : Findings from a multicenter, randomized, open-label, phase 3 trial ' , Headache , vol. 63 , no. 1 , pp. 79-88 . https://doi.org/10.1111/head.14439Test

مصطلحات موضوعية: atogepant, calcitonin gene–related peptide, gepant, migraine, migraine preventive

وصف الملف: application/pdf

الإتاحة: https://doi.org/10.1111/head.14439Test
https://curis.ku.dk/portal/da/publications/oncedaily-oral-atogepant-for-the-longterm-preventive-treatment-of-migraineTest(ae50c15f-fa50-445b-9b09-273be98064a4).html
https://curis.ku.dk/ws/files/374566530/Headache_2023_Ashina_Once_daily_oral_atogepant_for_the_long_term_preventive_treatment_of_migraine_Findings_from_a.pdfTest

View record in BASE

4

دورية أكاديمية

Time course of efficacy of atogepant for the preventive treatment of migraine: Results from the randomized, double-blind ADVANCE trial

المؤلفون: Schwedt, Todd J, Lipton, Richard B, Ailani, Jessica, Silberstein, Stephen D, Tassorelli, Cristina, Guo, Hua, Lu, Kaifeng, Dabruzzo, Brett, Miceli, Rosa, Severt, Lawrence, Finnegan, Michelle, Trugman, Joel M

المساهمون: This study was sponsored by Allergan (prior to its acquisition by AbbVie).

المصدر: Cephalalgia ; volume 42, issue 1, page 3-11 ; ISSN 0333-1024 1468-2982

مصطلحات موضوعية: Neurology (clinical), General Medicine

الإتاحة: https://doi.org/10.1177/03331024211042385Test

View record in BASE

5

دورية أكاديمية

Atogepant for the preventive treatment of chronic migraine (PROGRESS):a randomised, double-blind, placebo-controlled, phase 3 trial

المؤلفون: Pozo-Rosich, Patricia, Ailani, Jessica, Ashina, Messoud, Goadsby, Peter J., Lipton, Richard B., Reuter, Uwe, Guo, Hua, Schwefel, Brittany, Lu, Kaifeng, Boinpally, Ramesh, Miceli, Rosa, De Abreu Ferreira, Rosa, McCusker, Emily, Yu, Sung Yun, Severt, Lawrence, Finnegan, Michelle, Trugman, Joel M.

المصدر: Pozo-Rosich , P , Ailani , J , Ashina , M , Goadsby , P J , Lipton , R B , Reuter , U , Guo , H , Schwefel , B , Lu , K , Boinpally , R , Miceli , R , De Abreu Ferreira , R , McCusker , E , Yu , S Y , Severt , L , Finnegan , M & Trugman , J M 2023 , ' Atogepant for the preventive treatment of chronic migraine (PROGRESS) : a randomised, double-blind, placebo-controlled, phase 3 trial ' , The Lancet , vol. ....

الإتاحة: https://doi.org/10.1016/S0140-6736Test(23)01049-8
https://curis.ku.dk/portal/da/publications/atogepant-for-the-preventive-treatment-of-chronic-migraine-progressTest(22a583f6-a1a3-475a-8c34-12d7560a7965).html

View record in BASE

6

دورية أكاديمية

Linea guida per la gestione del nodulo benigno della tiroide causa di sintomi locali ; Associazione medici endocrinologi (AME), Istituto superiore di Sanità 2022 e Associazione Italiana della Tiroide (AIT); Associazione Italiana di Medicina Nucleare (AIMN); Associazione Nazionale Infermieri in Endocrinologia e Diabetologia (ANIED); Comitato Associazioni Pazienti Endocrini (CAPE); Federazione delle Associazioni dei Dirigenti Medici Ospedalieri Internisti (FADOI); Società Italiana di Anatomia Patologica e Citologia Diagnostica - Divisione Italiana della International Academy of Pathology (SIAPEC-IAP); Società Italiana di Endocrinologia (SIE); Società Italiana di Radiologia Medica ed Interventistica (SIRM); Società Italiana Unitaria di Endocrino-Chirurgia (SIUEC), Società Italiana Ultrasonografia in Medicina e Biologia (SIUMB)

المؤلفون: Papini, Enrico, Crescenzi, Anna, D’Amore, Annamaria, De Benedictis, Anna, Deandrea, Maurilio, Frasoldati, Andrea, Garberoglio, Roberto, Guglielmi, Rinaldo, Lombardi, Celestino Pio, Mauri, Giovanni, Miceli, Rosa Elisa, Polano, Paola, Puglisi, Soraya, Rago, Teresa, Triggiani, Vincenzo, Van Doorne, Dominique, Salvatore, Domenico

المصدر: L'Endocrinologo ; volume 24, issue 3, page 285-295 ; ISSN 1590-170X 1720-8351

مصطلحات موضوعية: General Medicine

الإتاحة: https://doi.org/10.1007/s40619-023-01265-yTest

View record in BASE

7

دورية أكاديمية

Safety and tolerability of ubrogepant following intermittent, high-frequency dosing:Randomized, placebo-controlled trial in healthy adults

المؤلفون: Goadsby, Peter J., Tepper, Stewart J., Watkins, Paul B., Ayele, Girma, Miceli, Rosa, Butler, Matthew, Severt, Lawrence, Finnegan, Michelle, Szegedi, Armin, Trugman, Joel M., Jakate, Abhijeet

المصدر: Goadsby , P J , Tepper , S J , Watkins , P B , Ayele , G , Miceli , R , Butler , M , Severt , L , Finnegan , M , Szegedi , A , Trugman , J M & Jakate , A 2019 , ' Safety and tolerability of ubrogepant following intermittent, high-frequency dosing : Randomized, placebo-controlled trial in healthy adults ' , Cephalalgia , vol. 39 , no. 14 , pp. 1753-1761 . https://doi.org/10.1177/0333102419869918Test

مصطلحات موضوعية: aminotransferases, CGRP, gepant, healthy participants, migraine

الإتاحة: https://doi.org/10.1177/0333102419869918Test
https://kclpure.kcl.ac.uk/portal/en/publications/c9648a15-22e6-4ca5-844a-7ff009ae3e62Test
http://www.scopus.com/inward/record.url?scp=85073952122&partnerID=8YFLogxKTest

View record in BASE